Guardion Health Sciences, Inc. (GHSI)
NASDAQ: GHSI · IEX Real-Time Price · USD
8.07
+0.07 (0.88%)
At close: May 3, 2024, 3:59 PM
7.97
-0.10 (-1.24%)
After-hours: May 3, 2024, 6:08 PM EDT
Guardion Health Sciences Revenue
In the year 2023, Guardion Health Sciences had annual revenue of $12.25M with 10.85% growth. Revenue in the quarter ending December 31, 2023 was $2.94M with 7.68% year-over-year growth.
Revenue (ttm)
$12.25M
Revenue Growth
+10.85%
P/S Ratio
0.85
Revenue / Employee
$1,360,950
Employees
9
Market Cap
10.27M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12.25M | 1.20M | 10.85% |
Dec 31, 2022 | 11.05M | 3.82M | 52.77% |
Dec 31, 2021 | 7.23M | 5.34M | 282.74% |
Dec 31, 2020 | 1.89M | 986.91K | 109.30% |
Dec 31, 2019 | 902.94K | -39.22K | -4.16% |
Dec 31, 2018 | 942.15K | 504.80K | 115.42% |
Dec 31, 2017 | 437.35K | 296.32K | 210.11% |
Dec 31, 2016 | 141.03K | 28.22K | 25.01% |
Dec 31, 2015 | 112.81K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Biofrontera | 34.07M |
Genetic Technologies | 5.78M |
Biomerica | 5.41M |
Aeterna Zentaris | 4.50M |
BioCardia | 477.00K |
Organovo Holdings | 242.00K |
China SXT Pharmaceuticals | 29.92K |
Bionomics | 15.00K |
GHSI News
- 5 weeks ago - Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 - GlobeNewsWire
- 3 months ago - What made Guardion Health stock double on Wednesday? - Invezz
- 3 months ago - Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor's Best Inc. - GlobeNewsWire
- 6 months ago - Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023 - GlobeNewsWire
- 9 months ago - Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023 - GlobeNewsWire
- 1 year ago - Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer - GlobeNewsWire
- 1 year ago - Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023 - GlobeNewsWire
- 1 year ago - Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022 - GlobeNewsWire